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Abstract
Background: Myelinating Schwann cells (mSCs) form myelin in the peripheral nervous system. Because of the works by us
and others, matrix metalloproteinase-9 (MMP-9) has recently emerged as an essential component of the Schwann cell
signaling network during sciatic nerve regeneration.
Methodology/Principal Findings: In the present study, using the genome-wide transcriptional profiling of normal and
injured sciatic nerves in mice followed by extensive bioinformatics analyses of the data, we determined that an
endogenous, specific MMP-9 inhibitor [tissue inhibitor of metalloproteinases (TIMP)-1] was a top up-regulated gene in the
injured nerve. MMP-9 capture followed by gelatin zymography and Western blotting of the isolated samples revealed the
presence of the MMP-9/TIMP-1 heterodimers and the activated MMP-9 enzyme in the injured nerve within the first 24 h
post-injury. MMP-9 and TIMP-1 co-localized in mSCs. Knockout of the MMP-9 gene in mice resulted in elevated numbers of
de-differentiated/immature mSCs in the damaged nerve. Our comparative studies using MMP-9 knockout and wild-type
mice documented an aberrantly enhanced proliferative activity and, accordingly, an increased number of post-mitotic
Schwann cells, short internodes and additional nodal abnormalities in remyelinated nerves of MMP-9 knockout mice. These
data imply that during the first days post-injury MMP-9 exhibits a functionally important anti-mitogenic activity in the wild-
type mice. Pharmacological inhibition of MMP activity suppressed the expression of Nav1.7/1.8 channels in the crushed
nerves.
Conclusion/Significance: Collectively, our data established an essential role of the MMP-9/TIMP-1 axis in guiding the mSC
differentiation and the molecular assembly of myelin domains in the course of the nerve repair process. Our findings of the
MMP-dependent regulation of Nav channels, which we document here for the first time, provide a basis for therapeutic
intervention in sensorimotor pathologies and pain.
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Introduction
Regenerative capacity of the peripheral nervous system depends
on the remarkable phenotypic plasticity of Schwann cells (SCs)
[1,2,3,4,5,6,7], increasingly employed in the regenerative medicine
approaches [8,9,10,11,12,13]. A number of molecular modulators
of SC signaling have been characterized in nerve development
[14,15]; however, the intrinsic factors that directly contribute to
the rigorous phenotypic reorganization in SCs during the nerve
and myelin repair remain poorly understood. It became evident
that the SC interactions with axons during the early post-injury
events influence the final outcome of nerve repair [2,16,17]. As
both non-myelinating and myelinating SCs de-differentiate, they
up-regulate the expression of glial fibrillary acidic protein (GFAP)
[18,19], required for the subsequent proliferation of SCs and the
initiation of axonal regeneration [20]. It has been long suspected
that certain proteolytic events are involved in suppressing SC
mitosis and axonal growth [16,21]. Consequently, we have
established that inhibition of matrix metalloproteinase (MMP)
activity immediately after sciatic nerve crush facilitates nerve
regrowth by enhancing the rate of SC mitosis [22].
The MMP family of zinc endopeptidases (24 individual enzymes
in humans) includes collagenases, gelatinases, matrilysins, strome-
lysins and membrane-type MMPs [23]. MMP proteolysis regulates
the levels and the functionality of extracellular matrix components
and cell surface signaling receptors [24]. In the damaged nerves,
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growth and recovery of neuronal function [22,25,26,27,
28,29,30,31]. In peripheral adult nerves, MMP-9 (gelatinase B)
is produces only after injury. After a lesion, MMP-9 is produced by
myelinating SCs (mSCs), immune and endothelial cells to promote
the breakdown of the myelin sheath, the blood-nerve barrier and
the SC basal lamina [32,33,34,35,36,37,38]. MMP-9 is a multi-
domain enzyme with wide-ranging substrate preferences. Our
earlier work suggests that MMP-9 controls the phenotypic
switching in SCs by activation of the extracellular-signal-regulated
kinase (ERK)1/2 via the neuregulin/ErbB and insulin growth
factor (IGF)-1 ligand/receptor systems [39]. As a result MMP-9
suppresses 5-bromo-2-deoxyuridine (BrdU) incorporation in
cultured primary SC and the injured nerves [39]. Having
established that MMP-9 knockout results in a high SC number
immediately post-injury [39], we herein aimed to determine the
effect of MMP-9 deletion on remyelination.
Remyelination relies on the reciprocal signaling between re-
differentiating SCs and regenerating axons. These concerted
events facilitate the specialization of the axonal plasma membrane
and myelin domains [3,4,5,40,41]. Each mSC forms a myelin
internode, separated from the next internode by a node of
Ranvier. Robust proliferation of SCs post-injury results in short
myelin internodes in remyelinated fibers [41]. The nodal
clustering of voltage-gated sodium (Nav) channels, required to
the generation of action potentials, restores the saltatory
conduction in remyelinated fibers [40,42]. Yet, dysregulation
and maladaptive clustering of Nav channels are frequently the
cause of sensorimotor neuropathies and neuropathic pain [43,44].
The present study provides evidence that immediately post-
injury a fine balance between MMP-9 and its specific endogenous
inhibitor [tissue inhibitor of metalloproteinases (TIMP)-1] is a key
parameter of the signaling network in the injured nerve. By
regulating SC mitogenesis and maturation, MMP-9 controls the
molecular and structural assembly of myelin domains in
remyelinated fibers. In addition, our experimental data establish,
for the first time, that MMPs control both the clustering and the
gene expression levels of Nav channels in the nervous system.
Results
Gene networks in the nerve and DRG after nerve injury
To identify the genes the expression of which was affected in the
sciatic nerve as a result of the injury, we performed genome-wide
transcriptional profiling of the transected and sham-operated
mouse sciatic nerves and the associated lumbar (L)4/5 dorsal root
ganglia (DRG) at days 1 and 5 post-transection. Because SCs de-
differentiate immediately distal and immediately proximal to
injury [2,17], both segments of the transected nerve were pooled
together for analyses and identified as the ‘‘injured’’ sample. We
identified that the expression of multiple genes was affected in the
injured nerve compared with a sham control. The listing and the
heatmap of the 50 top up-regulated genes are shown in Table 1,
and Fig. 1 and 2, respectively. The gene expression data have been
deposited to GEO database (accession # GSE33454). In
agreement with the earlier reports [45,46,47,48], the injury up-
regulated the expression of the genes coding for arginase I (an
enzyme involved in polyamine synthesis [4]), calcium-binding
S100A8/A9, chemokine cc- and cxc-motif ligands (e.g., ccl2-4,
ccl7, cxcl1, cxcl10 and cxcl14), cytokine ligands and receptors
(e.g., interleukins il1b, il1r2 and il7r) and additionally, toll-like
receptors (e.g., tlr1, tlr7, tlr2, tlr6 and tlr13). Furthermore, the
injury caused a multi-fold up-regulation of the genes that are
directly linked to proteolysis, cell adhesion, cell signaling, and
maintenance of the extracellular matrix, including TIMP-1 (the
top 6
th up-regulated gene in the system), tenascin C (TNC) that is
important in the immune response to tissue damage [42,48,49]
and neutrophil gelatinase-associated lipocalin-2 (NGAL)/lipoca-
lin-2 (LCN2), known to directly interact with MMP-9 [50,51].
A distinct set of genes was induced in the ipsilateral DRG at day
5 post-nerve injury (Table 1, and Fig. 1 and 2). Many of the up-
regulated genes are known to be linked to nerve injury, including
G-protein coupled receptor 151 (Gpr151), activating transcription
factor 3 (Aft3), galanin (Gal), neuropeptide Y (Npy), small proline-
rich repeat protein 1A (Sprr1A), cholecystokinin B receptor
(Cckbr), endothelin-converting enzyme like-1 (Ecel1) and many
others [52,53,54,55]. Among MMPs, the transcription of MMP-13
and MMP-16/MT3-MMP alone was modestly up-regulated in the
DRG samples at day 5 post-transection (Figs. 1, 2 and Table 1).
Our further bioinformatics analysis of the genome-wide
transcriptional profiling data identified that the MMP-9-induced
CD44 signaling cascade is the likely major signaling pathway that
is activated in the nerve microenvironment as a result of sciatic
nerve injury (Fig. 3). In addition to CD44 and MMP-9, this
cascade includes TIMP-1 and NGAL, both of which directly bind
MMP-9. Overall, these unbiased high-throughput data place
MMP-9 at the center of the event network that develops in the
injured nerve microenvironment shortly after injury.
MMP-9/TIMP-1 complex in nerve after injury
The MMP-9 proenzyme forms a stoichiometric, stable hetero-
dimer, 1:1 complex with TIMP-1 [23]. As a result, a fine balance
between MMP-9 and TIMP-1 is a major parameter in regulating
both the MMP-9 proenzyme activation and the active MMP-9
enzyme functionality in the tissue. A further analysis of the
expression levels of MMP-9 and TIMP-1 based on the
transcriptional profiling data revealed that the TIMP-1:MMP-9
signal intensity ratio increases approximately 10-fold from roughly
1:1 in the sham-operated nerve to a 1:11 ratio at days 1 and 5 in
the transected nerve (Table 2). At the same time, following the
injury or sham operation of the sciatic nerve, the TIMP-1:MMP-9
ratio does not change significantly in the DRG.
Normally, the levels of MMP-9 are exceedingly low in intact
adult nerves. In turn, in the injured nerve MMP-9 expression
increases sharply reaching its maximal value at day 1 post-injury
[35,36]. In agreement, gelatin zymography of nerve extracts
revealed that the level of MMP-9 was exceedingly low in the sham-
operated nerve samples. In turn, the level of MMP-9 sharply
increased post-injury. The monomer, homo- and heterodimer
species of the latent and active MMP-9 species were detected in
the distal and the proximal stumps of the transected nerves. In
contrast, similar levels of MMP-2 (gelatinase A), a related
gelatinase that is distinct from MMP-9, were present in the
sham-operated and transected nerve samples (Fig. 4A).
To further characterize the interactions of TIMP-1 with MMP-
9 in the regenerating nerve in the early hours after injury, we
employed RT-PCR, gelatin zymography of the purified samples,
immunoblotting and immunostaining of the nerve samples at 1, 3,
6 or 24 h after nerve crush. For the gelatin zymography analysis,
the MMP-9 species were first extracted from the nerves and then
purified from the extracts using gelatin Sepharose-beads. The
bound material was eluted and analyzed (Fig. 4A). Multiple MMP-
9 species were detected as early as 1 h post-injury in the crushed
nerve samples.
In sharp contrast with the MMP-9 protein we detected in the
nerve as early as 1 h after nerve crush, the MMP-9 mRNA was
detected much later in the nerve samples (Fig. 4A). Thus,
according to RT-PCR, the MMP-9 mRNA remained undetect-
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Injured sciatic nerve, day 1 Injured sciatic nerve, day 5 DRG, day 5
Gene Fold increase Gene Fold increase Gene Fold increase
S100a8 122.3 Tnc 46.6 Gpr151 25.1
Arg1 101.9 Arg1 28.8 Atf3 18.8
Shh 88.0 Timp1 22.9 Gal 17
S100a9 80.9 Trem2 22.1 Npy 16.8
Ccl4 72.0 Gpnmb 19.9 Sprr1a 15.9
Timp1 55.3 Fcgr4 19.0 Cckbr 9.1
Il1b 47.4 Shh 16.8 Tubb6 8.2
Clec4d 45.4 Ms4a7 14.6 Speer3 8.2
Slpi 41.0 Retnlg 14.3 Ecel1 7.1
Fpr2 33.0 Ms4a6d 14.2 Kif22 7
Gdnf 32.7 Cd68 13.6 Gadd45a 6.6
Chi3l3 28.0 Clec4d 13.5 Wfdc3 6.3
Ccl7 26.5 Cd84 13.3 Flrt3 5.7
Cxcl1 25.7 Chi3l3 13.3 Sez6l 5.6
Ms4a6d 25.3 S100a8 13.1 Slc6a4 4.6
Fcgr4 25.0 Btc 12.6 Nts 4.5
Cxcl14 22.8 Ccl4 11.3 Chac1 4.2
Hdc 21.4 Hmga1 11.2 Itga7 3.8
Sphk1 20.3 Cd52 10.2 S100a11 3.8
Sell 19.7 Slc15a3 10.2 Cryba2 3.7
Cxcl10 19.5 Gdnf 9.7 Speer1-ps1 3.6
Rsad2 18.7 Uhrf1 9.5 Stfa2 3.6
Ppbp 18.4 Hist1h2af 9.2 Camk1 3.5
Slc15a3 17.2 Fcer1g 8.9 Phlda1 3.4
Hmga1 15.6 Arl11 8.1 Gbp2 3.4
Socs3 15.5 Hist1h2ao 8.0 Ucn 3.4
Tnc 15.0 Cxcl16 7.7 Taf7l 3.3
Ccl3 14.4 Lgals3 7.7 Cxcl9 3.1
Ccl2 13.9 Hist1h2ad 7.6 Hn1 3
Rasgrf1 13.4 Lat2 7.4 Lipn 3
Ptx3 13.2 Lyz2 7.4 Akr1b8 3
Fos 13.0 Tlr13 7.3 Itpr1 2.9
Retnlg 12.7 Sirpb1 7.3 Lgals3 2.9
Junb 12.3 Cyp4f18 7.1 Bglap2 2.9
Cd52 11.9 Tes 7.0 Prc1 2.9
Sirpb1 11.9 Nckap1l 7.0 Stmn4 2.9
Clec4n 11.5 Cd53 7.0 C1qb 2.8
F10 11.4 Aif1 7.0 Serpinb1a 2.7
Tlr13 11.3 Hist1h2an 7.0 Gap43 2.7
Nptx2 10.7 Mest 6.9 Chst2 2.7
Il1rn 10.5 Gadd45a 6.8 Mmp16 2.6
Oasl1 10.3 Ccr5 6.7 Gadd45g 2.6
Lilrb4 9.3 Apoc2 6.6 Xdh 2.6
Ccl9 9.1 Hist1h2ah 6.5 Cyp1b1 2.6
Edn2 8.9 Ly86 6.4 C1qc 2.6
Slc7a11 8.8 Hist1h2ak 6.4 Aspscr1 2.5
Il1r2 8.8 Clec7a 6.1 Cacna2d1 2.5
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33664Figure 1. Heatmap of the genome-wide transcriptional profiling data of the murine sciatic nerve and the corresponding L4/5 DRG
from the same animals. Red and blue correspond to the high and the low expression levels, respectively. Color map inset shows the signal
intensity scale. Only the genes with the B:A ratio .4 are shown in a descending order. A, sham nerve; B, nerve day 1 post-transection; C, nerve day 5
post-transection; D, DRG corresponding to the sham-operated nerve; E, DRG corresponding to day 5 post-transection. The green dots point to TIMP-
1, TNC, NGAL, CD44, and MMP-9 induced in the injured nerve, and MMP-13 in the DRG. DRG, dorsal root ganglia.
doi:10.1371/journal.pone.0033664.g001
Table 1. Cont.
Injured sciatic nerve, day 1 Injured sciatic nerve, day 5 DRG, day 5
Gene Fold increase Gene Fold increase Gene Fold increase
Il7r 8.7 Laptm5 6.1 Rin1 2.5
Clec4e 8.7 Lpxn 6.0 Adfp 2.5
Tnfrsf12a 8.6 Cd44 6.0 Srxn1 2.5
The fold-increase was calculated in transected (distal and proximal, pooled) relative to the sham-operated nerve samples. TIMP-1, tenascin (Tnc), Cd44 and MMP-16 are
in bold. DRG, dorsal root ganglia.
doi:10.1371/journal.pone.0033664.t001
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33664able until 24 h post-injury in the crushed nerves. In turn, the
TIMP-1 mRNA was already present in the nerve 3 h after the
crush. The level of TIMP-1 then continued to increase further in
the crushed nerve.
According to the results of gelatin zymography and Western
blotting, a significant portion of MMP-9 was present in a form of
the high molecular weight, 200–250 kDa bands and as a 125–
130 kDa MMP-9/NGAL complex in the crushed nerve (Fig. 4A,
B). A disulfide bridge formation between the hemopexin domain
cysteine residues is required for the dimerization of MMP-9
[23,56]. In agreement, following the reduction with DTT, the high
molecular weight species dissociated and, as a result, generated the
,110 kDa proenzyme, the 86–88 kDa enzyme, and the low
molecular weight degraded forms of murine MMP-9 (Fig. 4B).
Overall, our studies provide valuable evidence that both the latent
and proteolytically active MMP-9 species were present in the
injured nerve as early as 1 h after crush. However, only after as
long as 24 h after the lesion, MMP-9 synthesis ensued in the
crushed nerve. These data imply that shortly after the lesion the
pre-synthesized MMP-9 protein was already present at the nerve
crush site.
In agreement, we detected the round-shaped TIMP-1-free
MMP-9-positive structures in the crushed nerve microenviron-
ment. The most likely they represent neutrophils [50,51,57,58],
which infiltrate the nerve shortly after the injury [59]. mSCs were
the main cell type that co-distributed TIMP-1 and MMP-9 at day
1 post-crush (Fig. 4C). Because of their 1:1 association with
myelinated (i.e., myelin basic protein (MBP)-reactive) axons, mSCs
appeared as characteristic crescent structures [60]. MMP-9 was
also observed in the axoplasm of myelinated fibers.
MMP-9 is required to maintain mature mSCs in vivo
After nerve injury, mSCs undergo de-differentiation, followed
by their proliferation that lasts over a week post-injury in rodents
[3,18]. To determine the role of MMP-9 in these events, we used
MMP-9 knockout (KO or MMP-9
2/2) homozygous mice. Gelatin
zymography confirmed the absence of the MMP-9 activity in the
injured nerve and the associated L4/5 DRG in MMP-9
2/2 mice
(Fig. 5A).
Immature Schwann cells express GFAP. Thus, during injury-
induced de-differentiation both non-myelinating and mSCs induce
GFAP at day 5 post-injury [3,18]. In order to distinguish the de-
differentiating mSC population, the crushed nerve sections were
stained for both GFAP and MBP at day 5 post-crush. The number
of the dual-reactive GFAP+/MBP+ cells per nerve area was
clearly elevated in the nerves of MMP-9
2/2 mice compared with
MMP-9
+/+ mice (Fig. 5B–C). These observations are consistent
with the parameters in both the crush site and a distal region,
which is 10–20 mm apart from the crush site (Fig. 5C). This later
finding eliminates the possibility of retrograde SC migration as the
main cause of the increased numbers of immature mSC.
Importantly, in MMP-9
2/2 mice the DAPI-positive cell counts
were also elevated in both regions. Immunoblotting confirms an
increased level of GFAP at the crush site at day 5 in both wild-type
and MMP-92/2 mice post-crush compared with the naı ¨ve nerve
(Fig. 5D). The MMP-9 KO, however, had no significant effect on
the total GFAP level relative to that of b-actin. This finding is
consistent with the finding that the elevated GFAP levels in MMP-
9
2/2 nerves are accompanied by an increase in total protein and
cell numbers (i.e., DAPI counts) due to an enhanced rate of mSC
mitosis after either MMP-9 gene deletion or MMP-9 activity
inhibition [22,34,39]. Collectively, these data suggest that MMP-9
is required to suppress the pre-mitotic de-differentiation of mSCs
and/or the to promote the post-mitotic maturation of mSCs in the
injured nerve. MMP-9, however, does not specifically regulate the
GFAP expression levels in SCs. Consistent with this suggestion,
MMP inhibition did not affect the GFAP mRNA level in the
injured nerve [22].
MMP-9 elicits an early anti-mitogenic role in SCs that
influences remyelination
De-differentiated mSCs enter the cell cycle and then re-
differentiate to support remyelination [3,18]. In our study, we
aimed to specifically assess whether the early anti-mitogenic action
of MMP-9 in Schwann cells (within day 4 post-injury) [39] affects
remyelination (day 27 post-injury). Because SCs begin to actively
proliferate at day 2 post-injury [18], and the anti-mitogenic MMP-
Figure 2. Gene expression profiling of the nerve samples.
Horizontal axis, the signal intensity of the individual genes (the log
scale). The genome-wide transcriptional profiling was performed using
the samples obtained from mice on days 1 and 5 post-transection. The
top 50 genes up-regulated in the injured sciatic nerve and the DRG
relative to the sham-operated controls are shown. DRG, dorsal root
ganglia.
doi:10.1371/journal.pone.0033664.g002
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administered daily between days 2 and 4 after nerve crush in
MMP-9
+/+ and MMP-9
2/2 mice. The nerves were allowed to
remyelinate and BrdU was detected at day 27 post-crush (Fig. 6A).
In both mouse strains, the nerves effectively remyelinated (Fig. 6B).
There was no significant difference in the myelin thickness,
evaluated by the G-ratio (a ratio of the axonal diameter to the fiber
diameter [61]) in normal (0.678660.003 and 0.636360.003) or
remyelinated (0.69460.003 and 0.678860.005) nerves of MMP-
9
2/2 and MMP-9
+/+mice, respectively. However, the number of
the cells that incorporated BrdU during the first 4 days post-crush
was significantly higher in the remyelinated nerves in MMP-9
2/2
mice compared with MMP-9
+/+ mice (Fig. 6C). These cells
localized mainly within the laminin-reactive SC structures. Based
on these data, we conclude that MMP-9 activity is not essential for
the regulation of myelin thickness. However, anti-mitogenic
MMP-9 activity within the first days post-injury pre-determines
the post-mitotic SC levels in remyelinated nerves.
MMP-9 controls myelin formation after injury
According to our bioinformatics analysis using Ingenuity,
laminin was linked to the MMP-9-dependent pathway in the
injured nerve (data not shown). Laminins are the essential
components of the SC basement membrane, mSC morphogenesis
and myelin ensheathment [62,63], and they are susceptible to
MMP-9 proteolysis [64]. Consistent with the data by others, the
levels of pan-laminin increased in remyelinated nerves of MMP-
9
2/2 mice (Fig. 6B–C). It is likely that MMP-9 proteolysis of
laminin may at least partly control mSC maturation and myelin
ensheathment. Furthermore, laminin 2 is required for establishing
both the proper length of myelin internodes and the nodal
clustering of Nav1.6 channels [65,66].
To analyze the effect of MMP-9 KO on the internodal length,
naı ¨ve and remyelinated (day 27 post-crush) sciatic nerves of MMP-
Figure 3. Pathway analysis based on the genome-wide transcriptional profiling suggests the presence of a functional link among
MMP-9 TIMP-1, NGAL and CD44. Green and red indicate down- and up-regulated genes in the injured nerve at day 1 post-transection. Color
intensity is directly proportional to the gene expression changes relative to sham-operated nerve. Ingenuity core pathway analysis was performed
with expression values cutoff set at 300. The shape of the protein symbol shows cytokines, peptidases, transmembrane receptors, kinases and
transporters. Lcn2, lipocalin-2/NGAL.
doi:10.1371/journal.pone.0033664.g003
Table 2. TIMP-1: MMP-9 ratio in the nerve samples.
Sham Nerve D1 Nerve D5 Nerve Sham DRG D5 DRG
MMP-9 225 1,238 550 183 186
TIMP-1 279 14,416 6,383 196 347
TIMP-1:
MMP-9 ratio
1.24 12.45 11.61 1.07 1.87
The normalized signal intensity of the MMP-9 and TIMP-1 genes was derived
from the genome-wide transcriptional profiling data. Note the dramatic
increase of the TIMP-1: MMP-9 signal intensity ratio on days 1 and 5 post-injury
(D1 and D5, respectively) in the peripheral nerve sample. DRG, dorsal root
ganglion, day 5 post-injury.
doi:10.1371/journal.pone.0033664.t002
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2/2 and MMP-9
+/+ mice were individually teased out and
stained for laminin 2 and a paranodal marker, Caspr [60]
(Fig. 6D). The internodal length was similar in naı ¨ve nerves of
MMP-9
2/2 (620616 mm) and MMP-9
+/+ (614615 mm) mice.
The internodal length was significantly reduced in remyelinated
fibers compared with naı ¨ve fibers of both mouse strains, due to an
anticipated effect of nerve injury on SC proliferation [41]. In
addition, the internodes of remyelinated fibers were approximately
24% shorter in MMP-9
2/2 mice (198.8612 mm) compared with
MMP-9
+/+ (258.4618 mm) mice. According to the DAPI staining,
cell numbers increased in regenerating nerves of MMP-9
2/2 mice
relative to MMP-9
+/+ mice, consistent with our previous
observations [39] and (Fig. 5C).
The nodes of Ranvier and the adjacent paranodes were examined in
naı ¨ve and remyelinated nerves of MMP-9
2/2 and MMP-9
+/+ mice.
We did not record any significant ultrastructural abnormalities of the
nodes in MMP-9
2/2 animals as compared with MMP-9
+/+ mice
(Fig. 6E). The teased nerve fibers were stained for both the nodal
Nav1.6 channel [67], the clustering of which has been reported to be
laminin-dependent [66], and myelin associated glycoprotein (MAG), a
paranodal protein [60] that is sensitive to MMP-9 proteolysis in vitro
[68]. We observed a significant difference in the Nav1.6 and MAG
immunoreactivity in both the naı ¨ve and remyelinated fibers in MMP-
9
2/2 mice compared with those in MMP-9
+/+ mice (Fig. 6F). The
MAG-reactive paranodes were elongated in the naı ¨ve nerves of MMP-
9
2/2 mice. The MAG immunoreactivity was elevated and appeared
diffuse in naı ¨ve nerves of MMP-9
2/2mice relative to MMP-9
+/+mice.
The MAG immunoreactivity was low in the remyelinated compared
with the naı ¨ve fibers in both mouse strains, however, slightly elevated in
remyelinated nerves of MMP-9
2/2 mice. Both the intensity and the
area size of the Nav1.6 immunoreactivity were significantly increased in
the naı ¨v ea n dr e m y e l i n a t e dn e r v e so fM M P - 9
2/2mice compared with
MMP-9
+/+ m i c e( F i g .6 F ) .T h ec l e a rd e m arcation and the shape of
Nav1.6 clusters were lost in MMP-9 KO mice. However, the motor
nerve conduction velocity (MNCV) was not significantly different
between normal and remyelinated nerves in MMP-9 KO mice as
compared with MMP-9
+/+ mice (Table 3). Taken together, our
findings suggest that MMP-9 directly regulates the molecular assembly
of the nodes and paranodes during nerve development and injury
rather than affects motor nerve conduction.
Figure 4. MMP-9/TIMP-1 relationship in the sciatic nerve. A, Left, Multiple murine MMP-9 species are detected by gelatin zymography. The
total extracts (10 mg total protein each) of the naı ¨ve (N), distal (D) and proximal (P) segments of the transected nerves were analyzed by gelatin
zymography. Right lane, the purified MMP-9 sample isolated from an aliquot (25 mg total protein) of the proximal nerve extract (P) is provided as a
reference. Middle, the purified MMP-9 samples isolated from the naı ¨ve (N) and crushed (I) nerve (50 mg and 25 mg total protein, respectively) 1, 3, 6
and 24 h post-injury were analyzed by gelatin zymography. Note a 26protein loading of the naı ¨ve samples relative to the injured samples. Right, 2%
agarose gel-electrophoresis of the RT-PCR products. The MMP-9 and TIMP-1 genes were amplified using the naive and crushed samples in the RT-PCR
reactions. The unique primers were used in a 35-cycle PCR reaction to generate a 153 bp MMP-9 fragment, and 129 bp and 141 bp TIMP-1 fragments.
GAPDH was used for sample normalization. Right lane (cDNA), the first strand cDNA control synthesized from the total mouse spleen RNA in the RT-
PCR reaction. B, High molecular weight forms of MMP-9 in the injured sciatic nerve. The reduced (+DTT) and unreduced (2DTT) purified MMP-9
samples (15 mg total protein each) isolated from the injured sciatic nerve 0, 1, 3, 6 and 24 h post-injury were analyzed by Western blotting with the
MMP-9 antibody. C, Immunofluorescence for MMP-9 and TIMP-1 co-localize in mSCs of crushed nerve 24 h post-injury. Upper panel, MMP-9 (green)
and TIMP-1 (red) co-localize in crescent structures of mSCs (arrows). Circular structures are MMP-9 but not TIMP-1 reactive (arrowheads). Lower panel,
MMP-9 (red) localizes in the cytoplasm of mSCs, marked with MBP (green). MMP-9 is also detected in axoplasm of mSCs (arrows). Scale bar, 10 mm.
doi:10.1371/journal.pone.0033664.g004
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channels in the injured nerve
High expression levels of certain Nav channels, including Nav1.8
and Nav1.7, have been linked to the development of sensorimotor
deficits and neuropathic pain [43]. Because of the developmental
changes in the Nav clustering and potentially compensatory effects
of constitutive MMP-9 KO on nerve conduction, we tested if
pharmacologic MMP-9 inhibition affects the expression of Nav1.8
and Nav1.7 channels in adult injured nerves. For this purpose, we
used a wide-range inhibitor of MMPs, GM6001 (10 mg/kg).
Earlier,GM6001wasshowntopromotethefunctionalregeneration
of sensory axons and to attenuate neuropathic pain [22,34].
GM6001 was injected i.p. daily for 5 days after nerve crush in rats.
GM6001 significantly suppressed the expression of Nav1.8 and
Nav1.7 channels in the crushed rat nerve compared to the vehicle
treatment (Fig. 7). This observation directly links the ability of
GM6001 to improve sensory recovery and inhibit neuropathic pain
to its ability to reduce the levels of Nav1.8 and Nav1.7 channels.
Discussion
The success of peripheral nerve repair depends largely on the
ability of SCs to proliferate and to provide trophic support to
regenerating axons. In addition to the proliferative and proin-
flammatory growth-regulating factors identified by the earlier
genome-wide profiling studies [45,46,47,48], our data reveal the
novel important cellular components including MMP-9, TIMP-1,
NGAL and CD44 in the injured nerve. It has been long suspected
that proteolysis is involved in suppressing SC mitosis and axonal
regeneration [16,21]. To this end, we have already established that
inhibition of MMP activity facilitates sciatic nerve regeneration by
promoting the rate of SC mitosis [22]. Herein, we determined that
MMP-9 produced in SCs either alone or complexed with its
specific endogenous inhibitor, TIMP-1, controls the status of SC
maturation and myelin formation in the injured nerve.
We identified TIMP-1 as one of the top up-regulated genes in
the injured nerve. By binding to the catalytic domain of the MMP-
9 enzyme, TIMP-1 blocks an access of substrates to the active site
of MMP-9 [23]. In addition and in contrast with other MMPs, the
MMP-9 proenzyme, via its C-terminal hemopexin domain, forms
a stable heterodimer stoichiometric complex with TIMP-1 [23].
As a result, a fine balance between MMP-9 and TIMP-1 is a major
parameter in regulating both the MMP-9 proenzyme activation
and the active MMP-9 enzyme functionality in the tissue. In the
course of the first 24 h after nerve crush, TIMP-1 expression
rapidly increases providing an excess of TIMP-1 relative to the
amounts of MMP-9 existing in the nerve microenvironment.
Despite the presence of the endogenous inhibitor in nerve, MMP-
9 activity is involved in immune cell infiltration, SC mitosis and
myelin proteolysis [34,35,36,39]. MMP-9 is produced by several
Figure 5. Immature mSCs accumulate in crushed MMP-9 KO nerves. A, Gelatin zymography of the sciatic nerve and the L4/5 DRG 24 h post-
crush samples in MMP-9
+/+ and MMP-9
2/2 mice. MMP-9, but not MMP-2 was diminished in MMP-9
2/2 samples (n=2/lane, pooled). B,
Immunofluorescence of GFAP (red) and MBP (green) at day 5 post-injury in MMP-9
2/2 and MMP-9
+/+. Transverse nerve section, crush site
(representative of n=3/group), Scale bar, 40 mm. Increased number of immature, GFAP+ mSCs in MMP-9
2/2 nerves. C, Morphometry of B and of
DAPI-positive cell counts at the crush site and 10–20 mm distal to crush site. (*, p,0.05). D, Immunoblotting for GFAP (,45 kDa) and b-actin in the
naive (N) and injured (I) nerve at day 5 post-crush (the crush site) in MMP-9
+/+ and MMP-9
2/2 mice (representative of n=4/group).
doi:10.1371/journal.pone.0033664.g005
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endothelial cells and macrophages [69], which continually
remodel the repairing nerve [59,70].
However, in the tissue MMP-9 is not always encumbered by
TIMP-1. Thus, neutrophils, which normally rapidly invade the
damaged nerve [59], are an abundant source of TIMP-1-free MMP-
9. In the neutrophil granules, TIMP-1-free MMP-9 co-exists with
N G A L .N G A Ld i r e c t l yb i n d sM M P -9 and, as a result, protects
MMP-9 from rapid degradation and self-destruction [50,51,71,72].
The pre-synthesized MMP-9 enzyme detected by gelatin zymogra-
phy shortly after nerve injury may be provided by the infiltrating
neutrophils. Alternatively, MMP-9 in the nerves may represent an
axoplasmic protein that has been transported from the DRG or the
SCs. MMPs, which are distinct from and additional to MMP-9, may
also associate with TIMP-1 and reduce its net inhibitory activity. In
contrast with MMP-9 and TIMP-1, both MMP-2 and its inhibitor
TIMP-2 are expressed at a baseline level shortly after injury (data not
shown). At day 5 post-injury, the levels of MMP-2, however, appear
to be highly elevated at the blood-nerve and perineurial barriers and
the SC basement and plasma membranes [69], consistent with a
distinct function for the MMP-9/TIMP-1 and MMP-2/TIMP-2
systems post-injury [34,69,73,74]. Because within one day of
transection the proximal (regenerating) and distal (degenerating)
nerve stumps induce both the MMP-9 mRNA [39] and protein
expression, we propose that the enzyme independently regulates the
initiation of both, axonal regeneration and degeneration.
Figure 6. Remyelinated nerves of MMP-9 KO mice exhibit more SCs, short internodes and aberrant Nav1.6 clusters. A, A schematic of
BrdU administration (100 mg/kg, i.p.) at days 2–4, followed by BrdU detection during remyelination (day 27 post-crush). B, Methylene blue Azure II
staining of transverse araldite-embedded nerves at day 27 post-crush, the crush site (top panel). Effective remyelination in MMP-9
+/+ and MMP-9
2/2
mice (representative of n=3/group). Immunostaining for BrdU (red) and laminin (green) after A. (bottom panel); longitudinal nerve section, the crush
site, day 27 post-crush. Increased number of cells that incorporate BrdU at days 2–4 post-crush remain in remyelinated nerves in MMP-9
2/2 mice
(representative of n=3/group). Scale bars, 50 mm. C, The mean BrdU+ cell counts and pan-laminin staining from B. 6 SEM in n=4/group (*, p,0.05).
D, Teased fibers in normal and remyelinated (day 27 post-crush) nerves in MMP-9
+/+ and MMP-9
2/2 mice: immunofluorescent staining for laminin a2
(green), Caspr (red) and DAPI (blue). The distance between two arrows represents a myelin internode. The graph represents the mean internodal
length (mm) 6 SEM presented in A (*, p,0.05). N.S., not significant. Scale bars: A, 30 mm (insets, 12006magnification). E, Electron microscopy of the
nodes of Ranvier and the adjacent paranodes in normal and remyelinated (day 27 post-crush) nerves in MMP-9
+/+ and MMP
2/2 mice. (a), Paranodal
loops in contact with the axolemma of a small myelinated fiber in MMP-9
+/+ mouse. (b), Desmosomal junctions between adjacent paranodal loops
(arrow) and nodal microvilli (arrowhead) in MMP-9
2/2 mouse. Inset shows a heminode with an axon-SC network (asterisk) in the juxtaparanodal
region. (c), The lipid-laden macrophages (M, upper left) in the crushed nerves of MMP-9
+/+ mouse. (d) The heminode (left) is myelinated in the
crushed nerve of MMP-9
2/2 mouse. The lipid-laden macrophages in close contact with the axolemma in the non-myelinated region (M, right). Scale
bar 1.33 mm in ‘‘a’’; 0.87 mm in ‘‘b’’ (2.0 mm in inset); and 1.67 mm in c–d. F, Immunostaining for Nav1.6 (red) and MAG (green) in teased nerve fibers.
The graph represents the mean Nav1.6 reactive clusters (red) signal area or the intensity 6 SEM (*, p,0.05). Scale bars, 3 mm.
doi:10.1371/journal.pone.0033664.g006
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promotes post-mitotic maturation of mSCs. In agreement, the
findings by others suggest that MMP-9 supports the mature
phenotype in myelinating oligodendrocytes [75,76,77] and MMP-
9 inhibition promotes proliferation of the oligodendrocyte
progenitors in the injured spinal cord [30]. MMPs, however, are
specific anti-mitogens to myelinating glia but not of monocytes
and/or microglia in the injured nerve and spinal cord [22,30]. It is
interesting to note that the hemopexin protein [78] and TIMP-1
[79] both, have recently been linked to the oligodendrocyte
maturation. Because in the injured nerves the endogenous MMP-9
level is elevated during SC proliferation, we suggest that MMP-9
largely contributes to the suppression rather than to the prevention
of SC proliferation.
MMP-9 regulates mitosis and phenotypic switching in SCs by
activation of ERK1/2 (but not p38 or JNK) via the neuregulin/
ErbB, IGF-1 and PDGF ligand/receptor signaling cascades [39].
Both, ERK1/2 activation and anti-mitogenic activity are likely
related to the proteolytic activity of MMP-9 that is sensitive to the
inhibition by GM6001 [22,39]. The non-proteolytic activity of the
hemopexin domain of MMP-9 alone was capable of activating
ERK1/2 in various cultured cells [56,80,81], including SCs [82].
In the latter, ERK1/2 activation was attributed to the MMP-9-
mediated activation of lipoprotein-related protein-1. Our bioinfor-
matics analysis, however, also identified CD44 as the key MMP-9
receptor in the injured nerves. CD44 is known to specifically bind
MMP-9 via its hemopexin domain and to activate the ERK1/2
signaling [83,84]. It is tempting to hypothesize that in agreement
with the observations by others MMP-9 or MMP9/TIMP-1
binding to cellular CD44 affects the CD44 signaling [85].
In the remyelinating nerves lacking MMP-9, mSCs are unable
to form long internodes. In agreement, MMP-2/MMP-9 inhibi-
tion results in the short internodes in myelinating DRG neurons in
culture [86]. We suggest that by increasing the SC numbers (via
mitosis) that line the regenerating axons, MMP-9 deletion results
in the short myelin internodes. The findings by others also suggest
that MMP-9 promotes the process extension of oligodendrocytes
[75,76]. The presence of short internodes, however, did not cause
any significant aberrations of motor nerve conduction in MMP-9
KO mice. It is possible that the functional redundancy in the
MMP family [86,87,88] was sufficient to compensate for the lost
functions of MMP-9 in nerve conduction. A possibility also exists
that MMP-9 selectively affects repair and adaptive changes of
sensory nerve fibers post-injury [22,34,35,73]. Consistent with our
present findings, recent data by Court et al. [88] demonstrate that
myelin thickness is not greatly affected in the nerves deficient in
MMP-9 and MMP-2. [88]. Yet, MMP-9 deficient nerves exhibit
large appositions of the myelin sheath and small Cajal bands [88],
the cytoplasmic channels, that transport MBP mRNA from
perinuclear to nodal regions [40]. Interestingly, MMP blockage
reduces the levels of MBP mRNA in the injured nerve [22]. Court
and colleagues provide additional evidence that gelatinases
modulate the size of SC compartments by regulating cleavage
and deposition of dystroglycan in nerve [88]. MMP inhibition
reverses the internodal shortening of dystroglycan-deficient SCs
[88], implying that the reduced MMP activity improves SC
elongation independent of dystroglycan.
The molecular assembly of the nodes of Ranvier is directly
linked to myelination [40]. During nerve development, nodal Nav
channel clustering depends critically on the laminin 2 complex
with its receptor, dystroglycan [65,66]. Thus, the SC-specific
deletion of laminin 2 and dystroglycan results in the Nav1.6
clusters with a small surface area [66]. It is plausible that the
diminished proteolysis of dystroglycan and laminin is the reason
for the large Nav1.6 channel clusters in MMP-9-deficient nerves
[88,89]. It has been suggested that Nav channel complexes are
forced into the nodes during size-filtration within the SC processes
[42]. MMP-9 proteolysis of MAG [68], involved in myelin
adhesion to the axolemma, may affect the molecular and
structural assembly of the paranodes [90]. MMP-9 also cleaves
tenascin C [91], a nodal Nav channel-binding protein [42] the
expression of which is significantly up-regulated in the injured
Figure 7. MMPi therapy blocks Nav1.7 and 1.8 channel induction in nerve. Taqman qPCR for Nav1.8 and 1.7 in normal or crushed (day 5) rat
sciatic nerve normalized to GAPDH. GM6001 or vehicle was administered i.p. immediately and then daily at days 1–5 after crush. The mean fold
increase 6 SEM to normal nerves (*, p,0.05; **, p,0.01, ANOVA, Tukey’s post-hoc test of n=6/group). NS, not significant.
doi:10.1371/journal.pone.0033664.g007
Table 3. MNCV in MMP-9
2/2 and MMP-9
+/+ mice.
MMP-9
+/+ MMP-9
2/2 p value
Normal nerve MNCV
(m/s)
51.362.6 54.162.6 NS
Crushed nerve MNCV
(m/s)
22.662.5 25.961.4 NS
Crushed MNCV/Normal
MNCV
0.45260.065 0.48260.025 NS
Motor nerve conduction velocity (MNCV) expressed as mean 6 SEM (n=7/
group) analyzed with a two-tailed, unpaired t-test or an unpaired t-test with
Welch’s correction when variances were unequal. NS, not significant.
doi:10.1371/journal.pone.0033664.t003
MMP-9 Controls Myelin Formation in Nerve
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e33664nerve. We have recently localized MMP-9 to the nodes and
paranodes of myelinated fibers (data not shown), in a close
proximity of these substrates. The ability of MMP inhibition to
suppress the expression of Nav1.7 and 1.8 channels may be
explained by inactivate ERK1/2 signaling in SCs and repressed
demyelination [34,39,44,92].
Overall, our study identifies the MMP-9/TIMP-1 axis as an
important component of the diversified biochemical and cellular
network in the injured peripheral nerve. This axis is essential to the
regulation of the state of SC maturation and axonal remyelination.
Our work also suggests that the role MMP-9 plays early post-
injury has implications on the outcome of remyelination. Finally,
the regulation of Nav channels by MMPs represents a novel
paradigm in the nervous system.
Materials and Methods
Reagents
Basic reagents were normally purchased from Sigma-Aldrich
(St. Louis, MO) unless indicated otherwise. The following
antibodies were used for immunodetection: polyclonal goat anti-
mouse MMP-9 (R&D Systems, Minneapolis, MN, cat. #AF909;
0.1 mg/ml), polyclonal goat anti-mouse TIMP-1 (R&D, cat.
#AF980; 0.1 mg/ml), rabbit anti-GFAP (Dako, Carpinteria, CA,
cat. #Z0334, 1:1000), mouse anti-human MBP (AbD Serotec,
Raleigh, NC, cat. #MCA686S, 1:250), rat anti-BrdU (Abcam,
Cambridge, MA, cat. #ab6326, 1:100), rabbit anti-Caspr (Santa
Cruz Biotechnology, Santa Cruz, CA, cat. #sc-25669, 1:25), goat
anti-MAG (Santa Cruz Biotechnology, cat. #sc-9544, 1:50), goat
anti-mouse Alexa-594 (Invitrogen, Carlsbad, CA, 1:400) and goat
anti-rabbit Alexa-488 (Invitrogen, 1:400). Rabbit anti-Nav1.6 (cat.
#S0438, 1:350), mouse anti-b-actin (cat. #A53166, 1:10,000),
rabbit anti-laminin (cat. #L9393, 1:300), rat anti-laminin a2 (cat.
#L0663, 1:100) were from Sigma. 49-6-diamidino-2-phenylindole
(DAPI; 1:20,000) was from Invitrogen. TIMP-1 from human
neutrophil granulocytes (cat. #612080) and BrdU (cat. #203806)
were purchased from Calbiochem (San Diego, CA). GM6001 (a
hydroxamate inhibitor of MMPs; Ki of 0.1–0.5 nM for MMP-1,
-2, -8 and -9, and of 27 nM for MMP-3) was purchased from
Chemicon (Temecula, CA).
Animals, surgeries and therapies
Adult female C57BL6/J mice (n=93), FVB.Cg-Mmp9tm1Tvu/
J (MMP-9
2/2, n=70; 20 g) and wild-type FVB/NJ (MMP-9
+/+,
n=70; 20 g) mice (all from Jackson Labs, Bar Harbor, ME) and
adult femaleSprague-Dawley rats (n=36,220–250 g;Harlan Labs,
Indianapolis, IN) were used in our studies. Sciatic nerve crush was
performed to study the mechanisms of nerve repair. Sciatic nerve
transection was performed to differentiate the distal (degenerating)
from the proximal (regenerating) events following nerve injury.
Animals were anesthetized with 4% isoflurane (Aerrane; Baxter,
Deerfield, IL) in 55% oxygen. The sciatic nerves were exposed
unilaterally at the mid-thigh level. Nerves were transected using
surgical scissors or crushed using fine, smooth-surface forceps (twice
for 5 sec each in rats and once for 3 sec in mice). A sham-operated
control included the sciatic nerve exposure, without any additional
manipulation.
BrdU administration (100 mg/kg/day) or vehicle (1 mM Tris,
0.8% NaCl, 0.25 mM EDTA, pH 7.4) was performed intraper-
itoneally (i.p.) at days 2, 3 and 4 post-crush. GM6001 therapy
(10 mg/kg/day) was injected i.p. in 10% DMSO immediately
after the sham or nerve crush surgery and then once daily for
additional 5 days. 10% DMSO in normal saline was used as a
vehicle. Animals were sacrificed by an i.p. overdose of rodent
anesthesia cocktail containing Nembutal (50 mg/ml, Ovation
Pharmaceuticals, Deerfield, IL) and Diazepam (5 mg/ml, Hos-
pira, Lake Forest, IL) in 0.9% saline (Steris Labs, Phoenix, AZ),
followed by a lethal i.p. injection of Beuthanasia (100–150 mg/ml,
Merck Animal Health, Whitehouse Station, NJ). The sciatic nerve
and L4/5DRG ipsilateral and contralateral to the injury site were
also isolated for the subsequent analyses. Animals were handled in
accordance with the NIH Guide for the Care and Use of
Laboratory Animals, and the Animal Component of Research
Protocols (# 09-035, 09-036), approved by the VA San Diego
Institutional Animal Care and Use Committee.
RT-PCR, genome-wide transcriptional profiling and
pathway analysis of the nerve samples
Total RNA was extracted from nerves and DRG using TRIzol
and purified using a RNeasy column (Qiagen, Valencia, CA). The
RNA purity was estimated by measuring the OD260/280 and the
OD260/230 ratios. The RNA integrity was assessed using an
Experion automated electrophoresis system (Bio-Rad). The
samples were analyzed by RT-PCR using the nucleotide primers
specific for murine TIMP-1 (Gene Bank # NM_001044384) and
MMP-9 (Gene Bank #NM_013599). The following primers were
used: 59-CATTCGCGTGGATAAGGAGT-39 and 59-AC-
CTGGTTCACCTCATGGTC-39 (the forward and reversed
primers, respectively) to generate a 153 bp MMP-9 fragment;
59-CACAGACAGCCTTCTGCAAC-39 and 59-CATTTCCCA-
CAGCCTTGAAT-39 (the forward and reversed primers, respec-
tively) to generate a 141 bp TIMP-1 fragment, and 59-
GCATCTGGCATCCTCTTGTT-39 and 59-TGGGGAACC-
CATGAATTTAG-39 (the forward and reversed primers, respec-
tively) to generate a 129 bp TIMP-1 fragment. The isolated RNA
samples were used to synthesize the first cDNA strand using a
SuperScript II Reverse Transcriptase System (Invitrogen). The
samples were further amplified using the respective cDNA
template and the primers in the 35-cycle PCR reactions with
Taq DNA polymerase (New England Biolabs Ipswich, MA).
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Gene
Bank #NM_008084) was used as a normalization control. The
following forward and reverse primers were used to amplify a
300 bp fragment of murine GAPDH: 59-TGTGTCCGTCGT-
GGATCTGA-39 and 59-TTGCTGTTGAAGTCGCAGGAG-
39, respectively. The amplified samples were analyzed by 2%
agarose gel-electrophoresis.
For the genome-wide transcriptional profiling, the total RNA
samples (500 ng each) were labeled using an Illumina RNA
Amplification Kit (Ambion, Austin, TX). The labeled RNA
samples (1,500 ng each) were hybridized 18 h at 58uCt oa
MouseRef-8 v. 2.0 Expression BeadChip featuring over 25,697
transcripts (Illumina, San Diego, CA). BeadChips were then
washed, developed using fluorolink streptavidin-Cy3 (GE Health-
care, Piscataway, NJ) and scanned using an Illumina BeadArray
Reader. The raw data were processed using Feature Extraction
software version 10.5. The initial analysis and normalization to the
median were performed using GeneSpring GX software (Agilent,
Santa Clara, CA). Differentially expressed mRNAs with the signal
intensities two-fold over the background standard deviation were
filtered by t-test. Only the statistically significant data (p,0.05)
were analyzed further to calculate the gene expression levels. The
individual genes with a 2-fold difference in their expression levels
among the distinct samples were analyzed using Ingenuity IPA 9.0
(Ingenuity Systems, Redwood City, CA) and NextBio software
(NextBio, Santa Clara, CA) to determine the regulatory and
signaling pathways. The heatmap charts were generated using
GenePattern software.
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(50 ng) and a 26Taqman Universal PCR Master Mix (Ambion)
were analyzed using a Mx4000
TM Multiplex Quantitative PCR
System (Agilent) and a one-step program: 95uC, 10 min; 95uC,
30 sec; 60uC, 1 min for 50 cycles. The following primers and the
Taqman probes containing a 59-FAM reporter and 39-BHQ-1
quencher dyes (Applied Biosystems, Foster City, CA XXX) were
used for rat Nav1.7 (Gene Bank # NM_133289): 59-GGAGGTC-
TATGCCAAACTCTTTT-39,5 9-ATGGCTCTTCCCTTCA-
GAGTTAC-39 and 59-GCAGCATTTACACATGGCTATGT-
39 - the forward and reversed primers and a probe, respectively);
and rat Nav1.8 (Gene Bank #NM_017247: 59-CACCGT-
GTTTTTCACAATGGAG-39,5 9-GGAAGGTACGGAGCA-
CAGACA-39 and 59-CTGTGTCATCGTCACCGTGAGCCT-
39 - the forward and reversed primers and a probe, respectively).
The controls without the cDNA (a ‘‘no template’’ control) showed
the absence of the contaminating DNA in the analyzed samples.
Relative mRNA levels were quantified using the comparative delta
Ct method [93] and GAPDH as a normalizer, using the primer
and probe sequences from our previous work [36]. The fold-
change between the experimental and control samples was
determined using the MX4000 software, as described [94].
MMP-9 purification using gelatin-sepharose beads
Sciatic nerve fragments were snap-frozen in liquid N2 and
stored at 280uC. Nerves were extensively washed in PBS to
remove the blood. The fragments were then extracted for 1 h on
ice using 50 mM Tris-HCl, pH 7.4, containing either 1% Triton
X-100, 0.2 M NaCl, 10 mM CaCl2,1 0 mM GM6001, the
proteinase inhibitor cocktail set III (Calbiochem) and 1 mM
phenylmethylsulphonyl fluoride. The protein concentration of the
extracts was measured using a Coomassie Protein Assay (Thermo
Scientific, Waltham MA) and then adjusted to equal 2 mg/ml
each. The extract aliquots (25–75 mg total protein each) were 10–
50-fold diluted using 20 mM Tris-HCl, pH 7.4, supplemented
with 150 mM NaCl, 10 mM EDTA, the proteinase inhibitor
cocktail set III and 1 mM phenylmethylsulphonyl fluoride. The
diluted extracts were then allowed to bind gelatin Sepharose-beads
overnight at 4uC. After extensive washing, the bound material was
eluted using 26SDS gel loading buffer [125 mM Tris-HCl,
pH 6.8, 4% (w/v) SDS, 0.005% Bromophenol Blue and 20% (v/v)
glycerol].
Gelatin zymography
The crude nerve extracts and the purified MMP-9 samples were
analyzed using precast 10% acrylamide gels co-polymerized with
0.1% gelatin. After electrophoresis, gels were washed twice in
2.5% Triton X-100 for 30–60 min at ambient temperature,
incubated for 16–18 h at 37uC in 50 mM Tris-HCl buffer,
pH 7.4, containing 10 mM CaCl2 and 1 mM ZnCl2, and stained
with Coomassie Blue R250 to visualize bands with gelatinolytic
activity.
Immunoblotting
Purified MMP-9 samples were separated using gradient 4–12%
acrylamide gels and then transferred onto an Immobilon-P
polyvinylidene fluoride (PVDF)-membrane. After blocking the
membrane in PBS containing 0.1% Tween-20 and 1% bovine
milk casein, the membrane was incubated with a goat anti-mouse
MMP-9 antibody followed by a donkey anti-goat IgG conjugated
with horseradish peroxidase and a SuperSignal West Dura
Extended Duration Substrate Kit (Pierce, Rockford, IL). The
crude nerve extracts were prepared using 50 mM Tris-HCl,
pH 7.4, containing 1% Triton X-100, 150 mM NaCl, 10%
glycerol, 0.1% SDS, 5 mM EDTA, 1 mM phenylmethylsulphonyl
fluoride, aprotinin and leupeptin (1 mg/ml each). Extract aliquots
(50 mg total protein) were analyzed using 15% acrylamide gels
(Bio-Rad, Hercules, CA) and transferred onto a nitrocellulose
membrane using an iBlot dry blotting system (Invitrogen). After
blocking the membrane using PBS containing 0.1% Tween-20
and 5% non-fat milk (Bio-Rad), the membranes were incubated
overnight at 4uC with the rabbit anti-GFAP (diluted in 5% BSA),
washed in TBS containing 0.1% Tween and then incubated 1 h at
ambient temperature with a horseradish peroxidase conjugated
goat anti-rabbit secondary antibody (Cell Signaling; Danvers, MA,
1:5,000 dilution). The blots were developed using an enhanced
chemiluminescence system (GE Healthcare). The membranes
were re-probed using a b-actin antibody to control equal protein
loading. The band density was measured in n=4/group using
Image J relative to the b-actin band density.
Immunofluorescence
Immunofluorescence was performed using both sciatic nerve
sections and teased fibers. Cryoprotected and OCT-embedded
transverse or longitudinal sciatic nerve sections (10 mm each) were
rehydrated in graded ethanol and PBS. Antigen retrieval was
performed using Antigen Retrieval Solution (Dako; 5 min at 95uC
and then 20 min at ambient temperature). For the BrdU
detection, the sections were rinsed in PBS, incubated 30 min in
2N HCl in PBS, digested 30 min at 37uC with 0.01% Trypsin and,
finally, washed with PBS. Non-specific binding was blocked with
10% normal goat serum. Teased nerve fibers were prepared by
separating nerve bundles using a pair of fine smooth microforceps.
Individual fibers were teased out using 0.20–0.22 mm acupunc-
ture needles (Vinco, Oxford Medical Supplies, Fairford, Glouces-
tershire, UK) on a glass slide, dried at ambient temperature and
stored at 220uC. Non-specific binding was blocked in PBS
containing 5% normal goat serum and 0.25% Triton X-100. The
slides were incubated 16–18 h at 4uC with a primary antibody
followed by 1 h incubation at ambient temperature with a species-
specific secondary antibody conjugated with Alexa 488 (green) or
Alexa 594 (red). The nuclei were stained with DAPI (5 min). The
absence of non-specific staining was confirmed using the non-
immune serum and by using the antigen-absorbed primary
antibody (e.g., a TIMP-1 antibody pre-absorbed for 1 h at
ambient temperature using 30 ng/ml recombinant TIMP-1). The
sections were mounted in a Slowfade Gold antifade reagent
(Molecular Probes). Morphometry: The images were acquired using
a Leica DMR microscope and Openlab 4.04 imaging software
(Improvision, Waltham, MA). The staining intensity and individ-
ual cell counts were assessed in a total of 12 transverse nerve
sections per group: 2 randomly selected areas/section, 2 sections/
animal, ,100 mm apart each, from 3 animals/group. Images were
analyzed using the Density Slicing module of Openlab 4.04. To
quantify internodal length in teased nerve fibers, a length of mm
was imaged and the average of 34 internodes from 6 mice/group
were analyzed using the Advanced Measurement modules of
Openlab 4.04 software. To quantify signal intensity and the total
area (mm2) of Nav1.6 clusters, mutant and control mice were
analyzed blindly at a 12006 magnification in the average of 42
nodes from 6 mice per group. The gain of Nav fluorescence was
maintained below the threshold of fluorochrome saturation and
consistent among the groups. The area of each Nav cluster to be
measured was traced two to three times, visually defining the
perimeter of the intensity using the Density Slicing module. ROI
(region of interest) measurements were done for calculation and
average of intensity and area of Nav cluster using the Binary
Operation and Advanced Measurement modules of Openlab 4.04
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diameter of the fiber.
Neuropathology and electron microscopy
Animals were perfused trans-cardially with 0.5% glutaraldehyde
in PBS. The sciatic nerves were isolated, fixed in 2.5%
glutaraldehyde in PBS, post-fixed in 1% aqueous osmium
tetroxide, dehydrated in a graded alcohol series and propylene
oxide and embedded in araldite. Thick sections (1 mm) were cut
with a glass knife on an automated Leica RM2065 microtome and
stained with Methylene blue Azure II for light microscopic
examination [36]. Thin sections (60–90 nm) were cut with a
diamond knife on an automated Leica microtome, stained with
uranyl acetate and lead citrate and analyzed using a Zeiss10
electron microscope operating at 80 keV. Morphometry: Axonal and
fiber diameters (mm) were measured in 16 randomly selected
fibers/section in 2 distal 1-mm-thick sections/animal and n=4/
group at 4006and 12006magnification. The measurement from
the total of 128 fibers/group was used to calculate the G-ratio (a
ratio of the axonal diameter to the fiber diameter [61]).
Nerve conduction
Motor nerve conduction velocity (MNCV) was measured under
halothane anesthesia (4% for induction and 2% for maintenance).
The sciatic nerve was stimulated at 5 V, 0.05 ms pulse width using
a 58019 Square Wave Stimulator (Stoelting, Chicago, IL) at the
sciatic notch or the ankle [95]. Evoked responses were recorded
from the interosseous muscles of the ipsilateral foot with fine
needle electrodes, amplified 100Xs (P15 AC Amplifier, Grass
Instruments, Quincy, MA) and displayed on an oscilloscope (5110
Storage Oscilloscope and 5D10 Waveform Digitizer, Tektronix,
Beaverton, OR). The difference in the response latency of the M
wave was recorded as the time required for motor nerve
conduction between the sciatic notch and the ankle. The median
difference in latency between the 3 pairs of notch- and ankle-
evoked M waves was recorded for each nerve in a fully extended
hind limb. MNCV was calculated as the distance between
stimulation sites divided by the M wave latency.
Data analyses
Statistical analyses were performed using KaleidaGraph 4.03
(Synergy Software, Reading, PA) and SPSS 16.0 (SPSS, Chicago,
IL) software by a two-tailed, unpaired Student’s t-test and, when
variances were unequal, by an unpaired t-test with Welch’s
correction. Analyses of variance (ANOVA) for repeated measures
were employed for comparing three or more groups, followed by
Tukey-Kramer post-hoc test. The p value equal or below 0.05 was
considered significant.
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